Shionogi
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Shionogi sits in the top decile of US sponsors by registered trial count (#351 of 15,742 sponsors by registered trial count).
Shionogi: 54 sponsored US clinical trials, 5 recruiting.
Shionogi sponsors 54 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 43 completed. 10 of these trials are in Phase 3-4 (later-stage) and 42 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy Volunteers, with 3 trials.
Top-decile sponsor footprint
Shionogi ranks in the top decile of sponsors by registered trial count (#351 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
43 of 47 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
54 total, page 2 of 2
A Study to Evaluate Daily Pravastatin, Fenofibrate or Pravafen in the Treatment of Combined Hyperlipidemia
NCT00459745
Safety and Efficacy Study of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic Conditions
NCT00491894
Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung Cancer
NCT00078390
A Phase 1 Study of S-3304 in Patients With Solid Tumors
NCT00033215
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 22 |
| Phase 2 | 20 |
| Phase 3 | 10 |
Therapeutic Areas
What is open in the Shionogi pipeline
5 recruiting of 54 indexed (9% open); 43 completed (80%).
Phase mix: 10 late (III/IV) vs 42 early (I/II) (early-phase heavy).
Top condition: Healthy Volunteers (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Shionogi: open-pipeline peers nationwide
Peers matched on 54 registered trials and 9% open enrollment, not the therapeutic-area sidebar.
Shionogi sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 54 trials (± recruiting share)
- AdventHealth Translational Research Institute · 54 trials · 24% recruiting
- Auburn University · 54 trials · 24% recruiting
- Brooke Army Medical Center · 54 trials · 11% recruiting
- Corcept Therapeutics · 54 trials · 11% recruiting
Sponsors near 9% open enrollment (± trial volume)
- University of Kentucky · 9% recruiting · 54 trials
- University of Vermont · 9% recruiting · 162 trials
- Eli Lilly and Company · 9% recruiting · 1,341 trials
- Lahey Clinic · 9% recruiting · 43 trials
Related
What to do with this Shionogi page
54 registered trials is a research-attention snapshot, not an endorsement of Shionogi or any single study.
- 5 of Shionogi's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy Volunteers is the condition Shionogi studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy Volunteers trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Shionogi pipeline card: 54 registered trials from official public datasets.Report a data error.